MedTrace Logo

HbA2 Leuven and Its Impact on HbA1c Results

NCT01909648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-07-07

No results posted yet for this study

Summary

The study is designed to demonstrate HbA2 Leuven mutation and to asssess its impact on routine HbA1c measurements.

Conditions

  • Family Study HbA2 Leuven Mutation.

Interventions

OTHER

Blood withdrawal

GENETIC

Blood withdrawal

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Davy MJ Kieffer, PhD · Universitaire Ziekenhuizen KU Leuven

  • Pieter Gillard, MD, PhD · Universitaire Ziekenhuizen KU Leuven

  • Koen Desmet, PharmD · Universitaire Ziekenhuizen KU Leuven

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01909648 on ClinicalTrials.gov